Clinical trial

A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin

NCT02162407

Study summary

ClinicalTrials.gov

A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record insulin detemir Normalized identity: insulin detemir View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention human soluble insulin Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1999-10-01

PhasePHASE1

Conditions

Diabetesverified · MONDO: diabetes mellitus

Healthyunresolved

Interventions

insulin detemirDRUG · verified · RxNorm: insulin detemir

human soluble insulinDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

GrazAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02162407 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.